berberine and glp-1 Supplements, Liquid GLP1 Drink Mix, Gut GLP 1 Boost for Metabolism GLP-Advantage+

methodology, L.T

doi: 10.3181/00379727-102-25338

Researchers from the German Center for Diabetes Research (DZD) and Helmholtz Munich, in collaboration with a colleague from the University of Santiago de Compostela in Spain, describe the development of incretin-based pharmacotherapy from its beginnings to the discovery of polyagonists

Cardiovascular Benefits: May help lower the risk of heart disease in patients managing obesity

A review of the relevant literature and the National Institute of Health clinical trial registry did not yield evidence that such a study has been published or is currently underway

REWIND (2019) Dulaglutide extended benefit into a broader, lower-risk population challenging the idea this was only for those with established disease